BENDAMUSTINE
bendamustine hydrochloride 25 mg injection, 1 vial
BENDAMUSTINE (10763L)
10763L
Manner of administration:Injection
Restriction 7972
Indication: Previously untreated stage III or IV mantle cell lymphoma
Treatment phase: Induction treatment
Restriction 7943
Indication: Previously untreated stage II bulky or stage III or IV indolent non-Hodgkin's lymphoma
Treatment phase: Induction treatment
Restriction 7944
Indication: Follicular lymphoma
Treatment phase: Re-induction treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 200 mg | # of repeats: 11 | DPMA: $255.46 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| BENDAMUSTINE EUGIA
(bendamustine hydrochloride 25 mg injection, 1 vial)
|
||||
| BENDAMUSTINE EUGIA
(bendamustine hydrochloride 100 mg injection, 1 vial)
|
||||
| BENDAMUSTINE HYDROCHLORIDE MEDSURGE
(bendamustine hydrochloride 25 mg injection, 1 vial)
|
||||
| BENDAMUSTINE HYDROCHLORIDE MEDSURGE
(bendamustine hydrochloride 100 mg injection, 1 vial)
|
||||
| Bendamustine Sandoz
(bendamustine hydrochloride 25 mg injection, 1 vial)
|
||||
| Bendamustine Sandoz
(bendamustine hydrochloride 100 mg injection, 1 vial)
|
||||
| Bendamustine Viatris
(bendamustine hydrochloride 25 mg injection, 1 vial)
|
||||
| Bendamustine Viatris
(bendamustine hydrochloride 100 mg injection, 1 vial)
|
||||